Legend Biotech Co. (NASDAQ:LEGN – Get Rating) has earned an average rating of “Moderate Buy” from the twelve brokerages that are covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a hold rating and eleven have given a buy rating to the company. The average 1-year price target among brokers that […]
Legend Biotech Co. (NASDAQ:LEGN – Get Rating) was up 3.9% on Wednesday . The stock traded as high as $48.13 and last traded at $48.07. Approximately 454,012 shares traded hands during trading, a decline of 27% from the average daily volume of 620,913 shares. The stock had previously closed at $46.28. Analyst Ratings Changes Several […]
Legend Biotech Co. (NASDAQ:LEGN – Get Rating) was the target of a large increase in short interest in the month of March. As of March 15th, there was short interest totalling 5,110,000 shares, an increase of 14.8% from the February 28th total of 4,450,000 shares. Based on an average daily volume of 614,800 shares, the […]
Legend Biotech Co. (NASDAQ:LEGN – Get Rating) was the recipient of a large growth in short interest during the month of March. As of March 15th, there was short interest totalling 5,110,000 shares, a growth of 14.8% from the February 28th total of 4,450,000 shares. Based on an average daily volume of 614,800 shares, the […]
DekaBank Deutsche Girozentrale boosted its holdings in shares of Legend Biotech Co. (NASDAQ:LEGN – Get Rating) by 11.8% during the 2nd quarter, Holdings Channel reports. The fund owned 13,845 shares of the company’s stock after buying an additional 1,459 shares during the period. DekaBank Deutsche Girozentrale’s holdings in Legend Biotech were worth $745,000 as of […]